Related Experiment Video
Updated: Apr 30, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
Isorhapontigenin (ISO) inhibited cell transformation by inducing G0/G1 phase arrest via increasing MKP-1 mRNA
Guangxun Gao1, Liang Chen, Jingxia Li
1Nelson Institute of Environmental Medicine, New York University School of Medicine,Tuxedo, NY, USA.
Abstract:
The cancer chemopreventive property of Chinese herb new isolate isorhapontigenin (ISO) and mechanisms underlying its activity have never been explored. Here we demonstrated that ISO treatment with various concentrations for 3 weeks could dramatically inhibit TPA/EGF-induced cell transformation of Cl41 cells in Soft Agar assay, whereas co-incubation of cells with ISO at the same concentrations could elicit G0/G1 cell-cycle arrest without redundant cytotoxic effects on non-transformed cells. Further studies showed that ISO treatment resulted in cyclin D1 downregulation in dose- and time-dependent manner. Our results indicated that ISO regulated cyclin D1 at transcription level via targeting JNK/C-Jun/AP-1 activation. Moreover, we found that ISO-inhibited JNK/C-Jun/AP-1 activation was mediated by both upregulation of MKP-1 expression through increasing its mRNA stability and deactivating MKK7. Most importantly, MKP-1 knockdown could attenuate ISO-mediated suppression of JNK/C-Jun activation and cyclin D1 expression, as well as G0/G1 cell cycle arrest and cell transformation inhibition, while ectopic expression of FLAG-cyclin D1 T286A mutant also reversed ISO-induced G0/G1 cell-cycle arrest and inhibition of cell transformation. Our results demonstrated that ISO is a promising chemopreventive agent via upregulating mkp-1 mRNA stability, which is distinct from its cancer therapeutic effect with downregulation of XIAP and cyclin D1 expression.
Insights
Isorhapontigenin (ISO), a Chinese herb isolate, shows promising cancer chemopreventive effects by inducing cell-cycle arrest and inhibiting cell transformation. ISO achieves this by upregulating MKP-1 mRNA stability, distinct from its cancer therapeutic mechanisms.
Area of Science:
- Phytochemistry
- Cancer Biology
- Molecular Pharmacology
Background:
- The chemopreventive potential of isorhapontigenin (ISO), a novel isolate from Chinese herbs, remains unexplored.
- Understanding the molecular mechanisms of ISO's activity is crucial for its therapeutic development.
Purpose of the Study:
- To investigate the cancer chemopreventive properties of ISO.
- To elucidate the underlying molecular mechanisms of ISO's anti-cancer activity.
Main Methods:
- Soft Agar assay to assess cell transformation inhibition.
- Cell-cycle analysis to evaluate cell-cycle arrest.
- Western blotting and quantitative PCR to analyze protein and gene expression.
- Gene knockdown and ectopic expression studies to confirm molecular targets.
Main Results:
- ISO significantly inhibited TPA/EGF-induced Cl41 cell transformation and induced G0/G1 cell-cycle arrest without cytotoxicity.
- ISO downregulated cyclin D1 expression at the transcriptional level by targeting JNK/C-Jun/AP-1 activation.
- ISO upregulated MKP-1 expression via increased mRNA stability and MKK7 deactivation, which was critical for its observed effects.
Conclusions:
- ISO demonstrates significant cancer chemopreventive potential by upregulating MKP-1 mRNA stability, leading to cell-cycle arrest and inhibition of cell transformation.
- These findings highlight a distinct mechanism for ISO's chemopreventive action compared to its cancer therapeutic effects.
Related Concept Videos
Negative Regulator Molecules
Inhibition of Cdk Activity
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Abnormal Proliferation

